Small airways test in idiopathic pulmonary fibrosis
Part of Lungs & breathing clinical trials.
This study measures how well the small airways in your lungs work if you have idiopathic pulmonary fibrosis (IPF). It aims to find better ways to assess the disease and could lead to improved care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with IPF (idiopathic pulmonary fibrosis)
- You have not had a sudden worsening of IPF in the past 6 months
- You do not have asthma, COPD, or similar chronic lung diseases
- You are not on long-term bronchodilators or steroid inhalers
- You are not on chronic steroids or immunosuppressant medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new inhaled medicine. You must be a healthy nonsmoker, have normal lung function, and agree to avoid certain medications and foods.
This study looks at how well people with IPF can exercise and how strong their breathing muscles are. It helps doctors understand the effects of IPF on daily activity.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study is looking at people with Idiopathic Pulmonary Fibrosis (IPF), a type of lung scarring. Researchers will use medical records to see if they can better predict how the disease will progress over time.
This study tests whether a new tablet called SYH2059 can help slow lung scarring in adults with idiopathic pulmonary fibrosis (IPF), a condition where lung tissue becomes thick and stiff over time. You'll take the study drug alongside your current lung treatment to see if it improves your breathing and lung function.
This trial tests how well different breathing tests measure relief from shortness of breath in people with asthma or COPD. It may help doctors find better ways to check how well treatments are working.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.